Riley D E, Chelimsky T C
Department of Neurology, University Hospitals of Cleveland and Case Western Reserve University School of Medicine, 1100 Euclid Avenue, Cleveland, OH 44106, USA.
J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):56-60. doi: 10.1136/jnnp.74.1.56.
Formal laboratory testing of autonomic function is reported to distinguish between patients with Parkinson's disease and those with multiple system atrophy (MSA), but such studies segregate patients according to clinical criteria that select those with autonomic dysfunction for the MSA category.
To characterise the profiles of autonomic disturbances in patients in whom the diagnosis of Parkinson's disease or MSA used criteria other than autonomic dysfunction.
47 patients with parkinsonism and autonomic symptoms who had undergone autonomic laboratory testing were identified and their case records reviewed for non-autonomic features. They were classified clinically into three diagnostic groups: Parkinson's disease (19), MSA (14), and uncertain (14). The performance of the patients with Parkinson's disease was compared with that of the MSA patients on five autonomic tests: RR variation on deep breathing, heart rate changes with the Valsalva manoeuvre, tilt table testing, the sudomotor axon reflex test, and thermoregulatory sweat testing.
None of the tests distinguished one group from the other with any statistical significance, alone or in combination. Parkinson's disease and MSA patients showed similar patterns of autonomic dysfunction on formal testing of cardiac sympathetic and parasympathetic, vasomotor, and central and peripheral sudomotor functions.
This study supports the clinical observation that Parkinson's disease is often indistinguishable from MSA when it involves the autonomic nervous system. The clinical combination of parkinsonism and dysautonomia is as likely to be caused by Parkinson's disease as by MSA. Current clinical criteria for Parkinson's disease and MSA that direct patients with dysautonomia into the MSA group may be inappropriate.
据报道,自主神经功能的正式实验室检测可区分帕金森病患者和多系统萎缩(MSA)患者,但此类研究是根据临床标准对患者进行分类的,这些标准将有自主神经功能障碍的患者归入MSA类别。
描述帕金森病或MSA诊断采用自主神经功能障碍以外标准的患者的自主神经紊乱特征。
确定47例患有帕金森综合征并伴有自主神经症状且已接受自主神经实验室检测的患者,并查阅其病历以寻找非自主神经特征。根据临床将他们分为三个诊断组:帕金森病(19例)、MSA(14例)和不确定(14例)。在五项自主神经测试中比较帕金森病患者与MSA患者的表现:深呼吸时的RR变异、瓦尔萨尔瓦动作时的心率变化、倾斜台试验、汗腺轴突反射试验和体温调节性发汗试验。
单独或联合使用时,没有一项测试能在统计学上显著区分这两组。在心脏交感神经和副交感神经、血管运动以及中枢和外周汗腺运动功能的正式检测中,帕金森病和MSA患者表现出相似的自主神经功能障碍模式。
本研究支持临床观察结果,即帕金森病累及自主神经系统时往往与MSA难以区分。帕金森综合征和自主神经功能障碍的临床组合由帕金森病引起的可能性与由MSA引起的可能性一样大。目前将有自主神经功能障碍的患者归入MSA组的帕金森病和MSA临床标准可能不合适。